COGT
Cogent Biosciences, Inc.
Stock
$31.02−0.57 (−1.80%)Close Oct 2, 2026
- Stock-based compensation, 2025
- $46M
- YoY, 2025
- +16.0%
- 5-year CAGR
- +50.3%
Stock-based compensation
Stock-based compensation by fiscal year
| Period | Stock comp | YoY |
|---|---|---|
| 2025 | $46M | +16.0% |
| 2024 | $40M | +29.8% |
| 2023 | $31M | +66.7% |
| 2022 | $18M | +57.2% |
| 2021 | $12M | +94.2% |
| 2020 | $6.0M | +85.7% |
| 2019 | $3.2M | +5.0% |
| 2018 | $3.1M | +130.3% |
| 2017 | $1.3M | — |